Sort
10,766 grants matching “checkpoint inhibitor”
The role of CADM1 in malignant melanoma
$109,440Edward Hartsough · Thomas Jefferson University · K99 · FY2018 · CA
The role of CADM1 in malignant melanoma
$109,440Edward Hartsough · Thomas Jefferson University · K99 · FY2017 · CA
Core A: Administration, Integration, Education and Career Development
$109,235Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2024 · CA
Targeting B7-H3 in ovarian cancer
$109,227Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Predictive Markers of Response to and Treatment Effects of Motixafortide, Cemiplimab, Gemcitabine and Nab-Paclitaxel in Treatment Naïve Metastatic Pancreatic Cancer
$109,080Michael Stevenson May · Columbia University Health Sciences · K38 · FY2025 · CA
Regulation of translation through the human translation initiation factor eIF5B
$108,729Assen G Marintchev · Harvard Medical School · K01 · FY2006 · CA
The Effects of Prior Checkpoint Inhibitor (CPI) Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$108,714Parizad Torabi-Parizi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Novel Mechano-Acoustic Enhancement of Immunotherapy
$108,473Ahmed El Kaffas · Stanford University · R21 · FY2023 · CA
Serial monitoring of circulating cell-free tumor DNA as measured by duplex sequencing in older patients with acute myeloid leukemia who receive azacitidine+venetoclax +/- immune checkpoint blockade
$108,302Patricia M Lorusso · Yale University · UM1 · FY2021 · CA
Parametric optimization of ultrasound-mediated immuno-modulation for pancreatic cancer therapy
$108,171Paul A Dayton · Univ Of North Carolina Chapel Hill · R21 · FY2021 · CA
Development Project 2
$108,067Beti Thompson · Fred Hutchinson Cancer Research Center · U54 · FY2013 · CA
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$108,000Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2019 · CA
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$108,000Maryam Rahman · University Of Florida · K08 · FY2021 · NS
Structure and Function of the Essential Cell Cycle Regulator Cdc34
$107,967Shaun Olsen · Medical University Of South Carolina · R01 · FY2020 · GM
ASSESSMENT OF THE MOLECULAR TARGET OF FUSAROCHROMANONE AND ITS ANALOGUES
$107,469Tara Williams-Hart · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2011 · RR
Roles of CD47 Signaling in Tumor Immunology
$107,268David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
DC AML Fusion Cell Vaccination with Immune checkpoint Blockade
$107,253Gordon James Freeman · Dana-Farber Cancer Inst · P50 · FY2018 · CA
Impact of BRCA1-mTORC2 interaction on breast cancer response to DNA damage and ch
$107,182Nicholas Taylor Woods · University Of Nebraska Medical Center · R21 · FY2014 · CA
Software for Predicting Liver Injury from Biologics Drug Candidates Using Data from a Human Liver Microphysiology System
$106,462Brett Alyn Howell · Dilisym Services, Inc. · R43 · FY2021 · TR
Mayo Clinic Breast Cancer SPORE
$106,181James Newell Ingle · Mayo Clinic Rochester · P50 · FY2010 · CA
Targeting the DNA Damage Response in HPV+ Head and Neck Cancer
$106,128Ahmed Mohamed Diab · Fred Hutchinson Cancer Research Center · K99 · FY2021 · DE
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$106,093Minah Kim · Columbia University Health Sciences · R37 · FY2025 · CA
Regulation of cyclosome/APC in the human cell cycle
$106,000Technion-Israel Institute Of Technology · R01 · FY2002 · GM
Investigating Immune Responses to Neoantigen Cancer Vaccines using In Vivo Functionalized Lineage
$105,840Camila Robles-Oteiza · Dana-Farber Cancer Inst · K00 · FY2025 · CA
Genome Integrity Through the Cell Cycle in Homeostasis and Cancer
$105,805Zachary Kenneth Mirman · Brigham And Women'S Hospital · K00 · FY2025 · CA